Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asia Leader Investments Limited is an investment holding company incorporated in the British Virgin Islands. It is primarily recognized as the principal shareholding vehicle for Dr. Xia Yu (Michelle Xia), the founder, chairwoman, and CEO of Akeso, Inc. The entity holds a significant ownership stake in Akeso, a leading biopharmaceutical company specializing in the development of multi-specific antibody drugs for oncology and immunology. Asia Leader Investments does not engage in independent research and development, clinical trials, or manufacturing operations. Its primary function is the management of equity interests and corporate governance within the life sciences sector, specifically relating to the leadership of Akeso.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asia Leader Investments.